OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: bpax

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) Scores FDA Approval for Male Testosterone Treatment Bio-T-Gel but Real Payday Continues to Rest on LibiGel

Having been left for dead back in December it appears that BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) has new life following the FDA approval of their testosterone-replacement product for men Bio-T-Gel, an approval that sent shares from a low of 0.68 … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , , | Leave a comment

BioSante Pharmaceuticals (NASDAQ: BPAX) Attracting Investors but FDA and Litigation Could Keep Share Price Down

BioSante Pharmaceuticals (NASDAQ: BPAX) has been working hard to convince investors that they are on the brink of entering the $2 billion female sexual dysfunction market with their transdermal testosterone gel LibiGel, a product designed to treat hypoactive sexual desire … Continue reading

Posted in Articles, NASDAQ, Penny Stocks | Tagged , , , , , , , , , , , | Leave a comment

BioSante Pharmaceuticals (NASDAQ: BPAX) Generating Big Volume on News of Pancreatic Cancer Treatment, Advancement of Female Sexual Dysfunction Drug

While BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) is billed as a specialty pharmaceutical company focused on developing products for female sexual health and oncology it is their news concerning a potential pancreatic cancer treatment that has driven volume to staggering heights … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , | Leave a comment